Form 4: Allovir Inc. Chief Accounting Officer Brett R. Hagen Reports Sale of Common Stock to Cover Tax Obligations
SEC Form 4 Filing
Brett R. Hagen, Chief Accounting Officer of Allovir, Inc., reports selling 304 shares of common stock on July 2, 2024, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On July 2, 2024, Brett R. Hagen, the Chief Accounting Officer of Allovir, Inc., sold 304 shares of common stock.
- The sale was executed at a price of $0.72 per share.
- The transaction was conducted to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the transaction, Hagen directly owns 75,177 shares of Allovir, Inc. common stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to stock transactions for tax purposes, indicating a neutral sentiment.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like officers and directors, trade their company's stock. These filings provide transparency into insider transactions, allowing investors to see if those with inside knowledge of the company are buying or selling shares.
Stakeholder Impact
- The sale of shares by an officer could be perceived negatively by some shareholders, although it is a common practice for covering tax obligations.
Key Dates
| Date | Description |
|---|---|
| 07/02/2024 | Date of the transaction: sale of common stock. |
| 07/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.